CFI and age-related macular degeneration: Further investigation has shown that CFI RV with abrogated function but normal levels (referred to as “Type II” variants) are also identified in a small proportion of AMD (39); almost 50% of CFI RVs identified in AMD are secreted at a similar level to WT in in vitro analyses (40).